Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Capital Leases (2016 - 2017)

Ekso Bionics Holdings (EKSO) has disclosed Capital Leases for 3 consecutive years, with $125000.0 as the latest value for Q1 2017.

  • On a quarterly basis, Capital Leases fell 39.32% to $125000.0 in Q1 2017 year-over-year; TTM through Mar 2017 was $125000.0, a 39.32% decrease, with the full-year FY2015 number at $226000.0, changed N/A from a year prior.
  • Capital Leases was $125000.0 for Q1 2017 at Ekso Bionics Holdings, down from $166000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $226000.0 in Q4 2015 to a low of $125000.0 in Q1 2017.
  • A 3-year average of $181800.0 and a median of $186000.0 in 2016 define the central range for Capital Leases.
  • Biggest YoY gain for Capital Leases was 39.32% in 2017; the steepest drop was 39.32% in 2017.
  • Ekso Bionics Holdings' Capital Leases stood at $226000.0 in 2015, then decreased by 26.55% to $166000.0 in 2016, then decreased by 24.7% to $125000.0 in 2017.
  • Per Business Quant, the three most recent readings for EKSO's Capital Leases are $125000.0 (Q1 2017), $166000.0 (Q3 2016), and $186000.0 (Q2 2016).